skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 11,097  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Immune Checkpoint Inhibitor‐Associated Myocarditis
Material Type:
Article
Add to My Research

Immune Checkpoint Inhibitor‐Associated Myocarditis

The oncologist (Dayton, Ohio), 2018-08, Vol.23 (8), p.879-886 [Peer Reviewed Journal]

AlphaMed Press 2018 ;AlphaMed Press 2018. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0130 ;PMID: 29802219

Full text available

2
Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update
Material Type:
Article
Add to My Research

Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update

The oncologist (Dayton, Ohio), 2019-10, Vol.24 (10), p.e990-e1005 [Peer Reviewed Journal]

AlphaMed Press 2019 ;AlphaMed Press 2019. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0337 ;PMID: 31217342

Full text available

3
CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer
Material Type:
Article
Add to My Research

CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer

The oncologist (Dayton, Ohio), 2018-09, Vol.23 (9), p.1079-1082 [Peer Reviewed Journal]

AlphaMed Press 2018 ;AlphaMed Press 2018. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2017-0674 ;PMID: 29866947

Full text available

4
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
Material Type:
Article
Add to My Research

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome

The oncologist (Dayton, Ohio), 2018-08, Vol.23 (8), p.943-947 [Peer Reviewed Journal]

Published 2018. This article is a U.S. Government work and is in the public domain in the USA ;Published 2018. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0028 ;PMID: 29622697

Full text available

5
Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
Material Type:
Article
Add to My Research

Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade

The oncologist (Dayton, Ohio), 2017-06, Vol.22 (6), p.627-630 [Peer Reviewed Journal]

2017 AlphaMed Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2016-0390 ;PMID: 28576858

Full text available

6
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Material Type:
Article
Add to My Research

BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors

The oncologist (Dayton, Ohio), 2023-09, Vol.28 (9), p.771-779 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press. 2023 ;The Author(s) 2023. Published by Oxford University Press. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad082 ;PMID: 37023721

Full text available

7
Early and Late Recurrence of Hepatitis B Virus‐Associated Hepatocellular Carcinoma
Material Type:
Article
Add to My Research

Early and Late Recurrence of Hepatitis B Virus‐Associated Hepatocellular Carcinoma

The oncologist (Dayton, Ohio), 2020-10, Vol.25 (10), p.e1541-e1551 [Peer Reviewed Journal]

AlphaMed Press 2020 ;AlphaMed Press 2020. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2019-0944 ;PMID: 32472951

Full text available

8
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study
Material Type:
Article
Add to My Research

Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study

The oncologist (Dayton, Ohio), 2020-05, Vol.25 (5), p.e808-e815 [Peer Reviewed Journal]

AlphaMed Press 2019 ;AlphaMed Press 2019. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2019-0473 ;PMID: 31740568

Full text available

9
Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma
Material Type:
Article
Add to My Research

Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma

The oncologist (Dayton, Ohio), 2018-01, Vol.23 (1), p.118-120 [Peer Reviewed Journal]

AlphaMed Press 2017 ;AlphaMed Press 2017. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2017-0344 ;PMID: 29158368

Full text available

10
Frequency of HLA-A02:01 in the Brazilian population and its impact on uveal melanoma systemic treatment
Material Type:
Article
Add to My Research

Frequency of HLA-A02:01 in the Brazilian population and its impact on uveal melanoma systemic treatment

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae112 ;PMID: 38785402

Full text available

11
Unleashing patient voices: empowering adverse event assessment with complete patient-reported outcomes
Material Type:
Article
Add to My Research

Unleashing patient voices: empowering adverse event assessment with complete patient-reported outcomes

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae105 ;PMID: 38785396

Full text available

12
High-value breast cancer care within resource limitations
Material Type:
Article
Add to My Research

High-value breast cancer care within resource limitations

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae080 ;PMID: 38780115

Full text available

13
Opioid metabolism and drug-drug interaction in cancer
Material Type:
Article
Add to My Research

Opioid metabolism and drug-drug interaction in cancer

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae094 ;PMID: 38780124

Full text available

14
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China
Material Type:
Article
Add to My Research

Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae095 ;PMID: 38780143

Full text available

15
Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective study
Material Type:
Article
Add to My Research

Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective study

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae104 ;PMID: 38775839

Full text available

16
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis
Material Type:
Article
Add to My Research

Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae099 ;PMID: 38776552

Full text available

17
A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer
Material Type:
Article
Add to My Research

A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae098 ;PMID: 38776551

Full text available

18
Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer
Material Type:
Article
Add to My Research

Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae101 ;PMID: 38767987

Full text available

19
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature
Material Type:
Article
Add to My Research

Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae093 ;PMID: 38768082

Full text available

20
Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy
Material Type:
Article
Add to My Research

Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy

The oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae089 ;PMID: 38768122

Full text available

Results 1 - 20 of 11,097  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2001  (220)
  2. 2001 To 2006  (1,076)
  3. 2007 To 2012  (1,672)
  4. 2013 To 2019  (3,948)
  5. After 2019  (4,182)
  6. More options open sub menu

Subject 

  1. Humans  (6,503)
  2. Oncology  (5,047)
  3. Female  (2,894)
  4. Male  (2,431)
  5. Middle Aged  (1,915)
  6. Adult  (1,885)
  7. Public, Environmental & Occupational Health  (1,763)
  8. Cell Biology  (1,610)
  9. Cell & Tissue Engineering  (1,610)
  10. Aged  (1,353)
  11. Stem Cells  (1,327)
  12. Original  (1,185)
  13. Surgery  (1,034)
  14. Cancer  (946)
  15. Animals  (906)
  16. Cancer Research  (856)
  17. Care And Treatment  (766)
  18. Analysis  (721)
  19. More options open sub menu

Language 

  1. Japanese  (3,009)
  2. Norwegian  (17)
  3. Chinese  (1)
  4. German  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait